Related Experiment Video

Updated: Feb 7, 2026

Author Spotlight: Innovative Technique for Coronary Angiography in Marginal Donors
06:25

Author Spotlight: Innovative Technique for Coronary Angiography in Marginal Donors

Published on: July 12, 2024

860

Relationship between serum adiponectin and osteoprotegerin levels and coronary heart disease severity

H L Zhang1, X Jin2

  • 1Department of Cardiology, Affiliated Hospital of Shandong Jining Medical College, Jining, Shandong, China HuilingZhang123@126.com.

Genetics and Molecular Research : GMR
|September 25, 2015
PubMed

Insights

Serum adiponectin levels are negatively linked to coronary heart disease (CHD) progression, while osteoprotegerin levels are positively correlated. Combined analysis may aid in determining CHD severity.

Area of Science:

  • Cardiovascular Research
  • Biomarker Discovery
  • Clinical Chemistry

Background:

  • Coronary heart disease (CHD) poses a significant global health burden.
  • Identifying reliable biomarkers for CHD progression is crucial for effective management.
  • Inflammatory and ischemia markers play a role in CHD pathogenesis.

Purpose of the Study:

  • To investigate serum adiponectin and osteoprotegerin levels in CHD patients.
  • To explore the correlation of these biomarkers with inflammatory factors (hs-CRP) and ischemia markers (Lp-PLA2, IMA).
  • To assess the potential of combined adiponectin and osteoprotegerin detection in determining CHD severity.

Main Methods:

  • Retrospective analysis of 347 CHD patients.
  • Measurement of serum levels for lipoprotein phospholipase A2 (Lp-PLA2), hypersensitive C-reactive protein (hs-CRP), ischemia modified albumin (IMA), adiponectin, and osteoprotegerin.
  • Statistical analysis to determine correlations between biomarkers.

Main Results:

  • Serum adiponectin showed negative correlations with Lp-PLA2 and hs-CRP, and a positive correlation with IMA.
  • Serum osteoprotegerin demonstrated positive correlations with Lp-PLA2 and hs-CRP, and a negative correlation with IMA.
  • A negative correlation was observed between serum adiponectin and osteoprotegerin levels.

Conclusions:

  • Serum adiponectin levels are inversely associated with CHD progression.
  • Serum osteoprotegerin levels are directly associated with CHD progression.
  • Combined assessment of adiponectin and osteoprotegerin may offer clinical value in evaluating CHD severity.

More Related Videos

Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease06:39

Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease

Published on: February 18, 2020

7.2K
Analysis of Coronary Vessels in Cleared Embryonic Hearts08:25

Analysis of Coronary Vessels in Cleared Embryonic Hearts

Published on: December 7, 2016

8.6K

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
391
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
492
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
534
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
283
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
703